DE3439716A1 - Novel use of somatostatin - Google Patents

Novel use of somatostatin

Info

Publication number
DE3439716A1
DE3439716A1 DE19843439716 DE3439716A DE3439716A1 DE 3439716 A1 DE3439716 A1 DE 3439716A1 DE 19843439716 DE19843439716 DE 19843439716 DE 3439716 A DE3439716 A DE 3439716A DE 3439716 A1 DE3439716 A1 DE 3439716A1
Authority
DE
Germany
Prior art keywords
somatostatin
intraspinal
infusions
analgesic
intraventricular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19843439716
Other languages
German (de)
Inventor
Joachim Dr.med. Chrubasik
geb. Hausmann Sigrun Dr.med. 7800 Freiburg Chrubasik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Curamed Pharma GmbH
Original Assignee
Curamed Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curamed Pharma GmbH filed Critical Curamed Pharma GmbH
Priority to DE19843439716 priority Critical patent/DE3439716A1/en
Priority to EP19850102588 priority patent/EP0154940B1/en
Priority to DE8585102588T priority patent/DE3579479D1/en
Priority to US06/709,549 priority patent/US4670418A/en
Publication of DE3439716A1 publication Critical patent/DE3439716A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/31Somatostatins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Somatostatin can be used in the form of intraspinal or intraventricular injections and infusions as an analgesic or anaesthetic.

Description

Neue Verwendung von SomatostatinNew uses of somatostatin

Gegenstand der deutschen Patentanmeldung P 34 09 062.2 ist eine neue Verwendung von Somatostatin, nämlich in Form von periduralen Injektionen und Infusionen als Analgetikum.The subject of German patent application P 34 09 062.2 is a new one Use of somatostatin, namely in the form of peridural injections and infusions as an analgesic.

Es wurde jetzt gefunden, daß auch intraspinale und sogar intraventrikuläre Injektionen und Infusionen von Somatostatin beim Menschen zu einer ausgeprägten, dem Morphin vergleichbaren, analgetischen Wirkung führen.It has now been found that also intraspinal and even intraventricular Injections and infusions of somatostatin in humans at a pronounced, produce analgesic effects comparable to morphine.

Dazu wurden Krebspatienten mit unerträglichen Schmerzen im terminalen Stadium oder auch bei postoperativen Schmerzen 250 ßg Somatostatin als Injektion und danach 10 bis 50 ßg Somatostatin pro Stunde als Infusion teils intraspinal, teils intraventrikulär appliziert. Diese Behandlungen führten zu einer ausgeprägten Analgesie, die der des Morphins vergleichbar ist. Die Infusionen wurden länger als 2 Wochen nebenwirkungsfrei vertragen.These were cancer patients with excruciating pain in the terminal Stage or in the case of postoperative pain, 250 μg somatostatin as an injection and then 10 to 50 ßg somatostatin per hour as an infusion, partly intraspinally, partly intraventricularly applied. These treatments resulted in a pronounced Analgesia comparable to that of morphine. The infusions were longer than Tolerated for 2 weeks without side effects.

Es wurde weiterhin gefunden, daß intradurale oder intraspirale Injektionen und Infusionen anästhetische Wirkung haben und anstelle üblicher Anästhetika eingesetzt werden können.It was also found that intradural or intraspiral injections and infusions have an anesthetic effect and are used instead of conventional anesthetics can be.

Gegenstand der vorliegenden Erfindung ist somit die Verwendung von Somatostatin in Form von intraspinalen oder intraventrikulären Injektionen und Infusionen als Analgetikum und intradurales oder intraspinales Anästhetikum, sowie die Verwendung von Somatostatin zur Herstellung von intraspinalen oder intraventrikulären Injektions- und Infusionslösungen als Analgetikum oder Anästhetikum.The present invention thus relates to the use of Somatostatin in the form of intraspinal or intraventricular injections and infusions as an analgesic and intradural or intraspinal anesthetic, as well as the use of somatostatin for the production of intraspinal or intraventricular injection and infusion solutions as an analgesic or anesthetic.

Als In3ekt»-onslösungen kommen prinzipiell dieselben Lösungen in Frage wie gemäß der Hauptanmeldung. Bei der intraventrikulären Applikation wird durch eine künstliche Öffnung des Kopfes Zugang zum Ventrikel geschaffen und hierhinein die Infusionslösung geleitet.In principle, the same solutions can be considered as connectivity solutions as according to the main application. In the case of intraventricular application, an artificial opening in the head provides access to the ventricle and into it the infusion solution passed.

Trotz der guten Verträglichkeit wird man die jeweils applizierte Menge an Somatostatin so niedrig wie möglich halten. Einige Ergebnisse deuten darauf hin, daß die Dosierung niedriger als bisher gewählt werden kann.Despite the good tolerability, the amount applied will be used in each case keep somatostatin as low as possible. Some results suggest that the dosage can be chosen lower than before.

Claims (2)

Patentansprüche 1. Verwendung von Somatostatin in Form von intraspinalen oder intraventrikulären Injektionen und Infusionen als Analgetikum und intradurales oder intraspinales Anästhetikum. Claims 1. Use of somatostatin in the form of intraspinal or intraventricular injections and infusions as analgesic and intradural or intraspinal anesthetic. 2. Verwendung von Somatostatin zur Herstellung von intraspinalen oder intraventrikulären Injektions- und Infusionslösungen als Analgetikum oder Anästhetikum.2. Use of somatostatin for the preparation of intraspinal or intraventricular injection and infusion solutions as an analgesic or anesthetic.
DE19843439716 1984-03-13 1984-10-30 Novel use of somatostatin Withdrawn DE3439716A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE19843439716 DE3439716A1 (en) 1984-10-30 1984-10-30 Novel use of somatostatin
EP19850102588 EP0154940B1 (en) 1984-03-13 1985-03-07 Use of somatostatin
DE8585102588T DE3579479D1 (en) 1984-03-13 1985-03-07 NEW USE OF SOMATOSTATIN.
US06/709,549 US4670418A (en) 1984-03-13 1985-03-08 Method of using somatostatin as an analgesic or an anesthetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843439716 DE3439716A1 (en) 1984-10-30 1984-10-30 Novel use of somatostatin

Publications (1)

Publication Number Publication Date
DE3439716A1 true DE3439716A1 (en) 1986-04-30

Family

ID=6249119

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19843439716 Withdrawn DE3439716A1 (en) 1984-03-13 1984-10-30 Novel use of somatostatin

Country Status (1)

Country Link
DE (1) DE3439716A1 (en)

Similar Documents

Publication Publication Date Title
DE69112717T2 (en) New use of Modafinil.
Saarne Clinical evaluation of the new analgesic piritramide
DE69131646T2 (en) METHOD AND MEANS FOR PROMOTING HAIR GROWTH AND IMPROVING THE SKIN CONDITION
DE19857609A1 (en) Use of erythropoietin for the treatment of human cerebral ischemia
EP0185210A2 (en) Use of dipeptide derivatives for the preparation of medicaments for the treatment of sufferers from amyotrophic lateral sclerosis
DE3439716A1 (en) Novel use of somatostatin
DE3432793A1 (en) COSMETIC PREPARATIONS, ESPECIALLY FOR TREATING SEBORRHOE AND ACNE, AND METHOD FOR THE PRODUCTION THEREOF
DE3416374C2 (en)
EP0154940B1 (en) Use of somatostatin
DE60024408T2 (en) USE OF TRICYCLIC ANTIDEPRESSIVA FOR THE TREATMENT OF HEADACHE
WO2005041948A1 (en) Punctual stimulation therapy
DE3239710T1 (en) PEPTIDES WITH NERVE REGENERATING PROPERTIES
DE2923955A1 (en) PHARMACEUTICAL AGENT FOR TREATING SEXUAL FRIGIDITY AND IMPOTENCE
DE2444652A1 (en) MEANS FOR CONTROLLING LOCAL PAIN
DE1617745A1 (en) Process for the manufacture of a medicament for the prevention and treatment of bleeding, pain, shock and harmful trauma effects
DE19804301C2 (en) Tincture for the treatment of inflammatory skin and mucosal changes
DE2038827C3 (en) Oral and dental care products for the prevention and improvement of gingivitis and for treating periodontal disease
DE2908127A1 (en) USE OF ENKEPHALINES AND ENDORPHINES INHIBITORS IN THE CONTROL OF PAIN, AND IN THE MANUFACTURING OF PHARMACEUTICAL PREPARATIONS AND MEDICINAL PRODUCTS
CA2030421C (en) Agent for treatment of cerebrovascular contraction
DE1806400A1 (en) Pharmaceutical product, in particular injectable lacal anesthetic
DE19703449A1 (en) Stable, tissue compatible, injectable calcitonin solutions
EP0189107A3 (en) Therapeutical peptide and/or amino acid composition
Zenz et al. Pain therapy with epidural morphine in patients with terminal cancer
CN1082406A (en) Compound vitamin A acid oil
Lee et al. Continuous Brachial Plexus Anesthesia Axillary Sheath Cannulation Using a Spinal Needle-Intravenous Catheter Combination

Legal Events

Date Code Title Description
AF Is addition to no.

Ref country code: DE

Ref document number: 3409062

Format of ref document f/p: P

8141 Disposal/no request for examination